EP2338420B1 - Implant médical destiné à la fermeture d'ouvertures de récipients - Google Patents

Implant médical destiné à la fermeture d'ouvertures de récipients Download PDF

Info

Publication number
EP2338420B1
EP2338420B1 EP10016014.2A EP10016014A EP2338420B1 EP 2338420 B1 EP2338420 B1 EP 2338420B1 EP 10016014 A EP10016014 A EP 10016014A EP 2338420 B1 EP2338420 B1 EP 2338420B1
Authority
EP
European Patent Office
Prior art keywords
implant
sealing elements
webs
central region
loops
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP10016014.2A
Other languages
German (de)
English (en)
Other versions
EP2338420A1 (fr
Inventor
Milisav Obradovic
Gerd Eisold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bentley Innomed GmbH
Original Assignee
Bentley Innomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Innomed GmbH filed Critical Bentley Innomed GmbH
Priority to EP10016014.2A priority Critical patent/EP2338420B1/fr
Publication of EP2338420A1 publication Critical patent/EP2338420A1/fr
Application granted granted Critical
Publication of EP2338420B1 publication Critical patent/EP2338420B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592—Elastic or resilient implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00597—Implements comprising a membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00637—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for sealing trocar wounds through abdominal wall
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00867—Material properties shape memory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00946—Material properties malleable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01—Filters implantable into blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents

Definitions

  • the invention relates to a medical implant for closing vessel openings and / or shunt connections between body vessels, which can be positioned minimally invasively in a contracted state and converted into an expanded state by having two spaced-apart, enlarged diameter sealing elements that the Seal the vessel opening or shunt connection on both sides, wherein the implant is made of a tubular body by introducing wall openings at least in the region of expanded in the expanded state having a sealing element.
  • occluders implants are already known.
  • EP 0 808 138 B1 an occluder made of a metal mesh of interwoven metal strands.
  • the occluder is placed by means of a catheter at the desired location in the vascular system of a patient and brought into the expanded state.
  • vessels of a patient can be closed, for example septal defects, such as defects of the atrial septum.
  • a persistent duct (PDA) or a ventricular septal defect can also be treated with occluders.
  • Another similar occlusion instrument is from the DE 10 2005 053 958 Al known.
  • This occlusion instrument also consists of a metal mesh with two umbrella-like sealing elements, wherein in the implanted state one of the sealing elements rests on one side of the vessel opening and the other sealing element on the opposite side of the vessel opening on the vessel wall and to be closed Vessel opening seals.
  • the US 2008/0249562 A1 discloses the subject matter of the preamble of claim 1.
  • the known occluders have the disadvantage that their production of thin metal wires or polymer fibers is relatively expensive.
  • the present invention is therefore based on the object to provide a occlusion implant that is easy to manufacture and to handle.
  • a medical implant for closing vascular openings and / or shunt connections between body vessels, which can be positioned minimally invasively in a contracted state and converted into an expanded state by having two spaced-apart, diameter-expanded sealing elements, with which the vessel opening or shunt connection can be sealed on both sides, wherein the implant is made of a tubular body by introducing wall openings at least in the region of expanded in the expanded state having a sealing element and wherein in the expanded state, the webs of each sealing element in Substantially perpendicular to the longitudinal axis of the implant and form radial loops in the region of each sealing element, which are open to the longitudinal axis of the implant, wherein the loops of each sealing element in each case substantially in one plane lie and the loops of the two sealing elements in the central region are connected to each other via substantially straight and mutually parallel webs.
  • the webs running essentially at right angles to the longitudinal axis of the implant in the region of the sealing elements make it possible to produce the implant with a very short length extension.
  • a further length reduction results from the fact that the webs of the sealing elements form radial loops, which in each sealing element for essentially lying in one plane. This feature is also essential for a short design of the implant.
  • the arrangement of the webs in open to the longitudinal axis of the implant loops leads to a umbrella-shaped or flower-like configuration of the sealing elements, which can optionally be easily covered with a membrane.
  • the loops allow a certain spring effect, which is why the implant can very easily adapt to the opening to be closed, for example in the septum of the heart. Even irregular openings are thus easy to close.
  • the substantially straight course of the webs in the central region which connect the loops of the two screens, allows an optimal adaptation to the thickness of the septum.
  • the straight and parallel course of the webs in the central region, which connect the loops of the two sealing elements together, also allows the variable production of the implants, i. the individual adaptation to the physiological conditions of the respective patient.
  • the implants according to the invention are thus not made of fabrics or nets which have previously been produced in relatively complicated processes from thin threads or wires.
  • the implant is made of a solid tubular body, which is provided with wall openings at least at the locations which form the sealing elements in the expanded state.
  • the wall openings can be preferably introduced by laser cutting in the tubular body. This method is highly accurate and relatively inexpensive.
  • the mutual distance of the wall openings can also be chosen such that the intervening wall webs of the tubular body are thicker than the threads or strands of the known occluders. As a result, implants according to the invention can be produced with a higher dimensional stability than the known occluders.
  • the wall openings are slot-shaped. This shape of the wall openings allows easy deformability of the tubular body, so that in the expanded state having an enlarged diameter sealing elements are easy to produce. Further advantages are obtained if a plurality of mutually parallel wall openings are provided. This measure also facilitates the deformability of the implant.
  • the mutual distance of the wall openings and their distribution over the circumference of the tubular body can be selected according to the desired properties of the implant.
  • the configuration of the wall openings determines the properties of the sealing elements.
  • the wall openings may extend substantially parallel to the longitudinal axis of the implant. As a result, they are easy to introduce into the tubular body and also ensure easy transfer of the implant in the expanded state. However, the wall openings may also extend at an acute angle to the longitudinal axis of the implant or extend helically over the circumference of the implant.
  • the implant is made of a shape memory alloy, in particular nitinol.
  • Nitinol also has resilient properties, so that the implant can be brought into the contracted state for insertion into the body of the patient and, for example, introduced by means of a catheter. At the target site, the catheter may be withdrawn, whereby the implant assumes the stored expanded form by being able to seal the vessel opening or shunt connection.
  • a shape memory polymer can also be used to produce the implant according to the invention.
  • Polymers also have excellent shape memory properties and are even easier to deform than nitinol.
  • liquid-tight membranes can be arranged in or on the sealing elements. These membranes are positioned with the help of the sealing elements on both sides of the vessel openings and held in this position.
  • the membranes can be made of different materials. In order to achieve high body compatibility, ePTFE is preferred as the material for the membranes.
  • ePTFE is preferred as the material for the membranes.
  • Such membranes can be sewn firmly to, for example, openings in the webs in the region of the loops and / or in the central region.
  • the slot-shaped wall openings of the central area merge into the slot-shaped wall openings in the area of the sealing elements.
  • the wall openings are thus made as a continuous, extending to the end portions of the tube slots.
  • the omission of a non-slotted tube section between the central region and the sealing element regions also leads to an easier deformability of the central region. It can thus be adapted more easily to different sizes and shapes of vessel openings or shunt connections. Often these have no round, but an oval or slit-shaped cross-section.
  • a single set of implants can accommodate a whole range of opening sizes and shapes.
  • the previously required storage of implants for different diameter sizes of the openings to be closed in a 1-millimeter grid can thus be significantly reduced.
  • An implant can now be used to supply diameters of openings of several millimeters.
  • the wall openings in the central region can extend in a spiral parallel to the longitudinal axis of the implant and in the region of the two sealing elements. After being transferred to the expanded state, the webs remaining between the wall openings in the sealing element regions form loops extending radially outwards.
  • the central area can also be upset, making it a bulbous shape. By twisting about the longitudinal axis, it can also be shortened in length become. The circumference of the central area adjusts to the circumference of the vessel opening or shunt connection after positioning of the implant at the site to be occluded.
  • the implant according to the invention may preferably be positionable in the body with the aid of a catheter or a helix.
  • the implant according to the invention can be guided and positioned through a guide wire.
  • the catheter or coil the implant can be moved with high accuracy through the patient's vascular system and positioned at the desired site of use.
  • the catheter or the helix can be connected to one of the ends of the implant by means of a screw connection or by means of a bayonet closure.
  • Fig. 1 shows a tubular body 20 for producing an implant 30, which has over the two sealing portions 31 and 32 and an intermediate central region 33 extending wall openings 38, which are also relatively wide, so that only a few wall webs 36 remain therebetween.
  • the wall openings 38 are thus made as a continuous, up to the end portions 34 and 35 of the tube extending slots.
  • the omission of non-slotted pipe sections between the central region 33 and the sealing element regions 31 and 32 leads to a slight deformability of the central region 33. It can thus be easily adapted to different sizes and shapes of vessel openings or shunt connections.
  • Fig. 2 showing the implant 30 in the expanded state.
  • the wall webs 36 form in the region of the sealing elements 31 and 32 radially outwardly projecting loops 37.
  • the wall webs 36 are parallel to each other, but have been pressed radially outwardly so that they compared to the pipe ends 34, 35 a significantly larger Include diameter between them, in the case shown about five times the diameter.
  • the radially outwardly projecting loops 37 of the sealing elements 31 and 32 extend approximately parallel and in the same direction.
  • the loops of a sealing element lie substantially in one plane.
  • Loops 37 of different sealing elements are connected to each other in the central region 33 by straight webs 36.
  • the same direction course of the loops of the respective sealing elements and the connection via webs 36 in the central region 33 results in a certain spring action, which causes a simple adaptation of the sealing elements and the implant to the opening to be closed.
  • Fig. 1 is still the opening of individual wall webs 36 in the region of the sealing elements 31 and 32 and shown in the central region 33, the sewing a liquid-tight membrane to the sealing elements enable.
  • Fig. 3 is the front view of the implant 30 is shown, from which the arrangement of a dot-dash line membrane 40 in the sealing region 31 is clear.
  • the membrane 40 made of a liquid-tight material can be stretched between the two halves of the radial loops 37 and fastened, for example, to the outer arcs of the loops 37. It is thus able to safely close a vessel opening whose diameter corresponds approximately to the diameter of the circle 41.
  • On the circle 41 which generally has approximately 2 to 15 times and in particular 4 to 10 times the diameter of the tube 20, are the portions of the wall webs 36 ( Fig. 2 ) in the central region 33 of the implant 30, which protrudes through the vessel opening after insertion of the implant 30.
  • a membrane 40 is arranged, so that the vessel opening is sealed from both sides.
  • the implants 10 'and 30 can also be used in vessel openings or shunt connections, which have no circular, but a more oval or slit-shaped cross-section. By a corresponding deformation of the wall webs 36 in the central region 33, these can also be brought into contact with the edge of the opening in the case of such vessel openings, thereby centering the implant 30.
  • the implants may be made, for example, from Nitinol or other metal alloy with shape memory or even from a shape memory polymer.
  • the membranes 40 in the region of the sealing elements may preferably be made of ePTFE, since this material is characterized by a very good body compatibility.
  • the implants 30 shown in the figures were produced by introducing slit-shaped wall openings 38 which run parallel to the longitudinal axis of the tubular body 20. However, this is not mandatory.
  • the openings 38 can with the longitudinal axis of the tubular Body 20 also form an angle, whereby the webs 36 form loops whose start and end points are offset in the tangential direction to each other. Spirally extending wall openings or other courses are possible.

Claims (16)

  1. Implant médical (30) pour l'obturation d'ouvertures de vaisseaux et/ou de liaisons shunt entre des vaisseaux, qui peut être placé de manière invasive au minimum dans un état contracté et qui peut être mis dans un état dilaté, du fait qu'il comprend deux éléments d'étanchéité (31, 32) de diamètre élargi écartés l'un de l'autre, qui étanchéifient l'ouverture du vaisseau ou la liaison shunt des deux côtés, l'implant (30) étant constitué d'un corps tubulaire (20) par la réalisation d'ouvertures de parois (38) avec la formation de nervures (36) au niveau des éléments d'étanchéité (31, 32) présentant un diamètre élargi dans l'état dilaté et dans la zone centrale (33) entre les éléments d'étanchéité (31, 32), caractérisé en ce que les ouvertures de parois (38) sont conçues comme des fentes traversantes s'étendant vers les zones d'extrémités (34, 35) du corps tubulaire (20), et dans l'état dilaté, les nervures (36) de chaque élément d'étanchéité (31, 32) s'étendent essentiellement perpendiculairement par rapport à l'axe longitudinal de l'implant (30) et forment, au niveau de chaque élément d'étanchéité (31, 32), des boucles radiales (37) qui sont ouvertes dans l'axe longitudinal de l'implant (30), les boucles (37) de chaque élément d'étanchéité (31, 32) se trouvant essentiellement dans un plan et les boucles (37) des deux éléments d'étanchéité (31, 32) étant reliés entre eux dans la zone centrale (33) par l'intermédiaire de nervures (36) essentiellement droites et parallèles entre elles.
  2. Implant selon la revendication 1, caractérisé en ce que plusieurs ouvertures de parois (38) parallèles entre elles sont prévues.
  3. Implant selon l'une des revendications précédentes, caractérisé en ce que les ouvertures de parois (38) s'étendent essentiellement parallèlement à l'axe longitudinal de l'implant (30).
  4. Implant selon l'une des revendications 1 ou 2, caractérisé en ce que les ouvertures de parois (38) forment un angle aigu avec l'axe longitudinal de l'implant (30).
  5. Implant selon l'une des revendications 1 ou 2, caractérisé en ce que les ouvertures de parois (38) s'étendent en spirale sur la périphérie de l'implant (30).
  6. Implant selon l'une des revendications précédentes, caractérisé en ce que les nervures (36) reliant les boucles (37) des deux éléments d'étanchéité (31, 32) dans la zone centrale (33) se trouvent approximativement sur le diamètre d'un cercle (41) qui présente un diamètre élargi par rapport au corps tubulaire (20).
  7. Implant selon la revendication 6, caractérisé en ce que le diamètre du cercle (41) est élargi par rapport au diamètre du corps tubulaire (20) d'un facteur de 2 à 15, de préférence de 4 à 10.
  8. Implant selon l'une des revendications précédentes, caractérisé en ce que les nervures (36) présentent, au niveau des boucles (37) et/ou dans la zone centrale (33), des passages pour la fixation d'une membrane (40).
  9. Implant selon l'une des revendications précédentes, caractérisé en ce qu'il peut passer de l'état dilaté dû à une déformation élastique réversible ou pseudo-élastique à un état contacté.
  10. Implant selon l'une des revendications précédentes, caractérisé en ce qu'il est constitué d'un alliage à mémoire de forme, plus particulièrement de nitinol, ou d'un polymère à mémoire de forme.
  11. Implant selon l'une des revendications précédentes, caractérisé en ce que, dans ou sur les éléments d'étanchéité (31, 32), se trouvent des membranes (40) étanches aux liquides.
  12. Implant selon la revendication 11, caractérisé en ce que les membranes (40) sont constituées de PTFE.
  13. Implant selon l'une des revendications 6 à 12, caractérisé en ce que, grâce à un aplatissement et/ou une torsion de la zone centrale (33), les deux éléments d'étanchéité (31, 32) peuvent être amenés en appui contre l'ouverture du vaisseau ou la paroi du vaisseau délimitant la liaison shunt et/ou la section transversale de la zone centrale (33) peut être adaptée à la section transversale de l'ouverture du vaisseau ou de la liaison shunt.
  14. Implant selon l'une des revendications précédentes, caractérisé en ce qu'il peut être positionné dans le corps à l'aide d' un cathéter ou d'un filament spiralé.
  15. Implant selon la revendication 14, caractérisé en ce que le cathéter ou le filament spiralé peut être fixé au niveau d'au moins une des extrémités (34, 35) de l'implant (30).
  16. Implant selon la revendication 15, caractérisé en ce que le cathéter ou le filament spiralé peut être vissé dans une des extrémités tubulaires (34, 35) de l'implant ou fixé à l'aide d'une fermeture à baïonnette.
EP10016014.2A 2009-06-09 2010-12-23 Implant médical destiné à la fermeture d'ouvertures de récipients Active EP2338420B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10016014.2A EP2338420B1 (fr) 2009-06-09 2010-12-23 Implant médical destiné à la fermeture d'ouvertures de récipients

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102009024390A DE102009024390A1 (de) 2009-06-09 2009-06-09 Medizinisches Implantat zum Verschließen von Gefäßöffnungen
DE202009017418U DE202009017418U1 (de) 2009-06-09 2009-12-23 Medizinisches Implantat zum Verschließen von Gefäßöffnungen
EP10005799A EP2260769A1 (fr) 2009-06-09 2010-06-04 Implant médical destiné à la fermeture d'ouvertures de récipients
EP10016014.2A EP2338420B1 (fr) 2009-06-09 2010-12-23 Implant médical destiné à la fermeture d'ouvertures de récipients

Publications (2)

Publication Number Publication Date
EP2338420A1 EP2338420A1 (fr) 2011-06-29
EP2338420B1 true EP2338420B1 (fr) 2013-05-29

Family

ID=41795555

Family Applications (2)

Application Number Title Priority Date Filing Date
EP10005799A Withdrawn EP2260769A1 (fr) 2009-06-09 2010-06-04 Implant médical destiné à la fermeture d'ouvertures de récipients
EP10016014.2A Active EP2338420B1 (fr) 2009-06-09 2010-12-23 Implant médical destiné à la fermeture d'ouvertures de récipients

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10005799A Withdrawn EP2260769A1 (fr) 2009-06-09 2010-06-04 Implant médical destiné à la fermeture d'ouvertures de récipients

Country Status (2)

Country Link
EP (2) EP2260769A1 (fr)
DE (3) DE202009014247U1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013019890A1 (de) * 2013-11-28 2015-05-28 Bentley Innomed Gmbh Medizinisches Implantat

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123715A (en) 1994-07-08 2000-09-26 Amplatz; Curtis Method of forming medical devices; intravascular occlusion devices
DE69529338T3 (de) * 1994-07-08 2007-05-31 Ev3 Inc., Plymouth Intravaskuläre Filtereinrichtung
WO1999038454A2 (fr) * 1998-01-30 1999-08-05 St. Jude Medical Cardiovascular Group, Inc. Structures de type connecteur ou bouchon pour greffes medicales et leurs procedes d'obtention et d'installation
US7128073B1 (en) * 1998-11-06 2006-10-31 Ev3 Endovascular, Inc. Method and device for left atrial appendage occlusion
WO2001045590A2 (fr) * 1999-12-23 2001-06-28 Percusurge, Inc. Modele d'entretoises pour dispositif d'occlusion
DE10127330A1 (de) * 2001-06-06 2002-12-12 Jomed Gmbh Implantate mit FK506 (b)
US6579302B2 (en) * 2001-03-06 2003-06-17 Cordis Corporation Total occlusion guidewire device
US20030139819A1 (en) * 2002-01-18 2003-07-24 Beer Nicholas De Method and apparatus for closing septal defects
DE602004018282D1 (de) * 2003-03-17 2009-01-22 Ev3 Endovascular Inc Stent mit laminierter dünnfilmverbund
CA2581677C (fr) * 2004-09-24 2014-07-29 Nmt Medical, Inc. Double systeme de fixation d'un dispositif d'occlusion pour l'administration/recuperation de ce dispositif d'occlusion
US7905901B2 (en) * 2004-11-29 2011-03-15 Cardia, Inc. Self-centering occlusion device
DE102005053958A1 (de) 2005-11-11 2007-05-16 Occlutech Gmbh Medizinisches selbstexpandierbares Occlusionsinstrument
US8109946B2 (en) * 2006-03-31 2012-02-07 W.L. Gore & Associates, Inc. Adjustable length patent foramen ovale (PFO) occluder and catch system
DE102006050385A1 (de) * 2006-10-05 2008-04-10 pfm Produkte für die Medizin AG Implantierbare Einrichtung
US9005242B2 (en) * 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
DE102008015781B4 (de) * 2008-03-26 2011-09-29 Malte Neuss Vorrichtung zum Verschluss von Defekten im Gefäßsystem

Also Published As

Publication number Publication date
EP2260769A1 (fr) 2010-12-15
DE202009017418U1 (de) 2010-04-22
EP2338420A1 (fr) 2011-06-29
DE202009014247U1 (de) 2010-03-04
DE102009024390A1 (de) 2010-12-16

Similar Documents

Publication Publication Date Title
EP2340770B1 (fr) Implant médical destiné à la fermeture d'ouvertures vasculaires
DE102009058132B4 (de) Zylindrischer Okkluder zur Abdichtung hohlzylindrischer Körpergefäße
DE60133081T2 (de) Implantat zum schliessen von defektöffnungen im menschlichen oder tierischen körper und vorrichtung zum einsetzen eines solchen implantats
DE102010045367B4 (de) Medizinische Vorrichtung zum Entfernen von Konkrementen
EP2799035B1 (fr) Implant pour influer sur la circulation du sang
DE69936415T2 (de) Gefässwundverschluss und Katheter
DE10338702B9 (de) Occlusioninstrument
EP0571422B1 (fr) Implant en spirale pour conduits du corps
DE102006040415B3 (de) Verschlusselement für ungewollte Öffnungen im Herzen, insbesondere Verschlusselement für Vorhofseptum-Defekt (ASD) oder Occlusionsinstrument
EP3273874B1 (fr) Dispositif de fermeture d'un appendice auriculaire cardiaque
DE102006050385A1 (de) Implantierbare Einrichtung
EP2145585B1 (fr) Fermeture de ponction destiné à fermer un organe creux comprenant une ouverture de ponction, notamment un vaisseau sanguin
DE202007019662U1 (de) Perkutane kathetergeführte intravaskuläre Verschlussvorrichtungen
DE102006036649A1 (de) Okkluder
EP3041439B1 (fr) Système d'insertion et de retrait d'implants
DE102016111568A1 (de) Implantat mit Ablösemechanismus
DE102012107175A1 (de) Medizinische Verschlussvorrichtung und System mit einer derartigen Verschlussvorrichtung
DE102015120554A1 (de) Bandförmiges Okklusionsmittel
EP3389511A1 (fr) Implant
EP3294217A1 (fr) Dispositif implantable pour améliorer ou supprimer une insuffisance valvulaire
EP2338420B1 (fr) Implant médical destiné à la fermeture d'ouvertures de récipients
DE102007061931A1 (de) Medizinisches Implantat
DE102012003021A1 (de) Membrangesteuertes Occlusionsinstrument zum Verschluss des linken Herzohrs
EP3073935B1 (fr) Système servant à relier un implant médical à un auxiliaire d'insertion
WO2012049197A1 (fr) Dispositif médical, en particulier endoprothèse

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

17P Request for examination filed

Effective date: 20120328

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BENTLEY INNOMED GMBH

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 613867

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130615

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502010003414

Country of ref document: DE

Effective date: 20130725

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130830

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130930

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130829

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130909

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130929

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130829

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: LUCHS AND PARTNER AG PATENTANWAELTE, CH

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20140303

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010003414

Country of ref document: DE

Effective date: 20140303

BERE Be: lapsed

Owner name: BENTLEY INNOMED G.M.B.H.

Effective date: 20131231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20131223

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131231

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20131223

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20141231

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20101223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151223

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 613867

Country of ref document: AT

Kind code of ref document: T

Effective date: 20151223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151223

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130529

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502010003414

Country of ref document: DE

Representative=s name: HOEFER & PARTNER PATENTANWAELTE MBB, DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20230103

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231219

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231229

Year of fee payment: 14

Ref country code: CH

Payment date: 20240110

Year of fee payment: 14